Noninvasive Optical Measurement of Critical Care Neonates

This study has been completed.
Sponsor:
Collaborator:
Beckman Laser Institute University of California Irvine
Information provided by (Responsible Party):
Beckman Laser Institute and Medical Center, University of California, Irvine
ClinicalTrials.gov Identifier:
NCT01483703
First received: November 29, 2011
Last updated: June 12, 2015
Last verified: June 2015
  Purpose

The purpose of this study is to determine whether reflections of light can be used to provide real-time pictures of blood vessel formation around infants' heads. This study device is called laser speckle imaging.


Condition Intervention
Signs and Symptoms
Device: Laser Speckle Imaging

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Noninvasive Optical Measurement of Critical Care Neonates

Resource links provided by NLM:


Further study details as provided by University of California, Irvine:

Primary Outcome Measures:
  • Medical tool [ Time Frame: up to 12 months ] [ Designated as safety issue: No ]
    Laser Speckle Imaging device to image superficial cerebral blood flow in the infant's head


Enrollment: 6
Study Start Date: May 2010
Study Completion Date: May 2012
Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Diagnostic tool
Laser Speckle Imaging of Critical Care Neonates
Device: Laser Speckle Imaging
Laser Speckle Imaging of Critical Care Neonates
Other Name: Laser Speckle Imaging

Detailed Description:

The researchers can use the laser speckle imaging device to image superficial cerebral blood flow in the infant's head. The researchers can quantify blood flow and measured vessel diameter, versus actual diameter assessed with conventional digital camera imaging.

  Eligibility

Ages Eligible for Study:   up to 6 Weeks
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Children

Criteria

Inclusion Criteria:

  • New born or infant

Exclusion Criteria:

  • non- new born or infant
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01483703

Locations
United States, California
CHOC
Orange, California, United States, 92868
Sponsors and Collaborators
University of California, Irvine
Beckman Laser Institute University of California Irvine
Investigators
Principal Investigator: Bernard Choi, PhD Beckman Laser Institute, UCI
  More Information

No publications provided

Responsible Party: Beckman Laser Institute and Medical Center, Bernard Choi, Ph.D., Assistant Professor Biomedical Engineering, University of California, Irvine
ClinicalTrials.gov Identifier: NCT01483703     History of Changes
Other Study ID Numbers: NIH-LAMMP-2010-8163
Study First Received: November 29, 2011
Last Updated: June 12, 2015
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Signs and Symptoms

ClinicalTrials.gov processed this record on July 27, 2015